GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial

Figure 3

Kaplan-Meier survival curves for ESCC patients with lower and higher GASC1 expressions.